FDA grants orphan status for AlzeCure’s pain drug candidate

AlzeCure Pharma CEO Martin Jönsson and CMO Märta Segerdal. Credit: AlzeCure Pharma AB.



  • FDA grants orphan status for AlzeCure’s pain drug candidate